ClinicalTrials.Veeva

Menu

Aromatherapy and Pain

University of Washington logo

University of Washington

Status

Withdrawn

Conditions

Chronic Pain

Treatments

Drug: Placebo packet
Drug: Aromatherapy packet

Study type

Interventional

Funder types

Other

Identifiers

NCT05910892
STUDY00007869

Details and patient eligibility

About

Effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain.

Full description

The study will explore the effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain. This will be a blinded study where patients will act as their own control over two treatment visits. On one visit patient will be exposed to either the aromatherapy or a placebo. On their second visit patients will be exposed to the other compound. The study will collect demographic data, pain intensity and affect, and catastrophizing information.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have received at least one (1) prior IMS or trigger point injection treatment with researcher
  • 18 years of age or older
  • English language speaker
  • has completed Pain Tracker (clinic standard of care) questionnaire prior to study visit
  • any analgesic medication taken must be consistent for both sessions

Exclusion criteria

  • Non-English language speaker
  • Age <18
  • Allergy to essential oils
  • Asthmatic
  • Patient unable to self-administer aromatherapy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

0 participants in 2 patient groups, including a placebo group

Aromatherapy before treatment
Active Comparator group
Description:
Subject receives aromatherapy before IMS treatment or trigger point injection
Treatment:
Drug: Aromatherapy packet
Placebo before treatment
Placebo Comparator group
Description:
Subject receives placebo before IMS treatment or trigger point injection
Treatment:
Drug: Placebo packet

Trial contacts and locations

0

Loading...

Central trial contact

Lisa Y Flint

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems